Willis, Alexander B.
Zelikovich, Aaron S.
Sufit, Robert
Ajroud-Driss, Senda
Vandenborne, Krista
Demonbreun, Alexis R.
Batra, Abhinandan
Walter, Glenn A.
McNally, Elizabeth M.
Article History
Received: 15 April 2024
Accepted: 4 November 2024
First Online: 20 November 2024
Declarations
:
: EMM has been a consultant to Amgen, AstraZeneca, Cytokinetics, Pfizer, Tenaya Therapeutics, and is a founder of Ikaika Therapeutics. ARD is CSO of Ikaika Therapeutics. The other authors have declared that no conflict of interest exists. There are no nonfinancial conflicts to report.